Product DescriptionRapid immunochromatographic combination test for qualitative detection of SARS-CoV-2 (COVID-19) and Influenza A and B antigens in human nasopharyngeal or oropharyngeal swab specimens. Designed for preliminary differential screening to support clinical triage; positive or inconclusive results should be confirmed by laboratory methods.
Key Features- Qualitative antigen detection
- Simultaneous detection of SARS-CoV-2, Influenza A and Influenza B antigens
- Specimen type: human nasopharyngeal or oropharyngeal swab
- Rapid preliminary differential screening of COVID-19 and Influenza A/B
- Test technology: Colloidal Gold immunochromatographic assay
Technical specifications- Intended use: Qualitative detection of SARS-CoV-2 and Influenza A/B antigens for preliminary screening
- Detection method: Colloidal Gold immunoassay
- Analytes: SARS-CoV-2 antigen, Influenza A antigen, Influenza B antigen
- Specimen type: Nasopharyngeal swab or oropharyngeal swab (human)
- Result type: Qualitative (positive/negative) for each target
- Product format: Combination (combo) test kit for simultaneous detection of COVID-19 and Influenza A/B